Immune consequences of gastrointestinal colonization of CD-1 and CBA/J mice with Candida albicans in the presence or absence of continuous antibiotic treatment with penicillin-tetracycline or trimethoprimsulfamethoxazole were investigated. Intubation with C. albicans in the absence of antibiotics resulted in the induction of low but detectable delayed-type hypersensitivity (DTH), demonstrable by footpad testing with a C. albicans wall glycoprotein (GP), and in the stimulation of a moderate level of protective immunity, demonstrable by intravenous (i.v.) challenge. DTH to a membrane extract, BEX, could not be detected in such animals. However, animals colonized in the presence of antibiotics and then inoculated cutaneously prior to being tested for DTH or protective immunity developed significantly enhanced levels of DTH to GP and BEX and were protected to an even greater extent than animals colonized in the absence of antibiotics who were not inoculated cutaneously. The priming effect of colonization, particularly with respect to the antigen GP, was also obvious from an enzyme-linked immunosorbent assay for GP-specific antibody with sera.of mice surviving the i.v. challenge, in that GP-specific antibody was present in the highest titers in colonized animals that had been inoculated cutaneously prior to i.v. challenge. While the antibiotics promoted higher levels of colonization, as evidenced by stomach and fecal cultures of intubated mice, antibiotic administration was not necessary for the induction of C. albicans-specific responses. Moreover, contrary to reports in the literature, antibiotic administration had no adverse effect on the immune responses measured. Females were innately more resistant than males to i.v. challenge with C. albicans, but each sex was capable of developing protective immunity of equal intensity in response to colonization or immunization by cutaneous challenge. 
The gastrointestinal (GI) tracts of infant and adult humans are often colonized with Candida spp., most often Candida albicans (3) , and it is generally believed that in most instances, disseminated candidiasis results from systemic spread from this site. Although transient innocuous episodes of C. albicans fungemia may occur by passage across the normal mucosa (17) , invasion in the individual, resulting in either mucosal or systemic disease or both, seems to occur only under conditions of compromise. Conditions of compromise are many and varied, but one of the most important nonimmunologic conditions is prolonged antibacterial antibiotic therapy (11, 24, 31) . The relationship of the antibiotics to the development of candidiasis has been debated for some time. It is clear that antibacterial antibiotics alter the ecological balance in the gut and that enhanced growth of Candida spp. occurs; the immunologic effects of the antibiotics themselves with respect to Candida spp., particularly in vivo, are not clear (22, 31) . Most of the research involving effects of various antibiotics on the immune system has been done in vitro by using chemotactic or phagocytic assays (12, 21, 22, 31) .
The research presented here was undertaken to investigate the in vivo immunologic consequences of GI colonization with C. albicans in the presence or absence of antibacterial antibiotics. A murine model of candidiasis in which the immunologic responses to cutaneous immunization with viable C. albicans cells have been well defined (4, 10, 23) conidia were stored frozen in PBS-inhibitor prior to fractionation.
Subcellular components of C. albicans were prepared from the blastoconidia suspended in PBS-inhibitor by disruption with ballistic action in a Braun homogenizer followed by differential centrifugation as described previously (4) . The three antigens used in this study, BEX, soluble cytoplasmic substances (SCS), and wall glycoprotein (GP), were derived from the membrane-mitochondrion fraction, soluble cytoplasm, and cell walls respectively. BEX was obtained by extraction of the membranes and mitochondria first with butanol and then with warm PBS followed by precipitation of the proteins with ammonium sulfate (4) . SCS was a lyophilized preparation of the soluble material remaining in the supernatant following a 144,000 x g centrifugation of disrupted cells. GP, a water-soluble glycoprotein, was extracted from lipid-extracted cell walls with ethylenediamine (16) and stored at room temperature in the lyophiized state. Protein determinations were done on each preparation by the method of Lowry et al. (20) .
Antibiotic treatment and animal inoculations. Mice were 8 to 12 weeks of age at the start of all experiments. When trimethoprim-sulfamethoxazole (Bactrim; Hoffman-La Roche Inc., Nutley, N.J.) was used for treatment, it was supplied in the drinking water so that each mouse received approximately the comparable human dose per day on a milligram-per-kilogram basis. Estimating that the average mouse in our colony weighed 20 g and dranked approximately 4 ml of water per day, we prepared the solution so that each mouse received approximately 0.1 and 0.46 mg of trimethoprim and sulfamethazole, respectively, per day. When penicillin-tetracycline was used for treatment, acidified (pH 2.5) drinking water was supplemented with 100 mg of tetracycline and 30 mg of penicillin per 100 ml.
Animals were inoculated with 2 x 107 viable C. albicans cells intragastrically (i.g.) via a stainless steel feeding tube, or with 106 viable blastospores cutaneously, or with 1 x 104 or 2 x 104 viable blastoconidia intravenously (i.v.), the desired concentration being contained in 0.1, 0.05, and 0.5 ml of nonpyrogenic saline, respectively.
Footpad testing. Mice were footpad tested by inoculation of 0.02 ml of nonpyrogenic saline containing 20 25, 4, 7, 24 , and 48 h after antigen was injected. The mean net increase in thickness was determined by subtracting preinjection measurements from postinjection measurements. Unimmunized animals were used as controls.
Antibody detection. Antibodies to SCS or GP in mouse sera were detected by using a solid-phase, double-antibody enzyme-linked immunosorbent assay as described previously (14) . Peroxidase-labeled sheep anti-mouse immunoglobulin G (IgG) (whole molecule) (Sigma Chemical Co., St. Louis, Mo.) was used as the enzyme-antibody conjugate. Absorbance values that were greater than 2 standard deviations above the mean value for a panel of negative sera were considered positive.
Calculations and statistical analyses. CFU per kidney in mice challenged i.v. for the assessment of protection were determined on the basis of standard dilution calculations, and statistical analyses were performed on the logarithmic values of these. Because death prior to sacrifice would bias calculations, a normalization factor equivalent to the maximum CFU detected in kidneys within that given experiment was assigned to each animal that died. Data were analyzed by Student's t test. Significance was determined at the P < 0.05 level.
Experimental design. The manner in which the mice were immunized and the times at which the various immune responses were measured were based on previous studies of candidiasis in CBA/J mice (4, 10, 23) . The interval between i.g. inoculation of C. albicans and the initiation of immunization with the cutaneous inoculation, ranging from 1 to 3 weeks, was chosen arbitrarily. Kidneys were cultured for the assessment of protection 25 to 28 days following i.v. challenge. Mice were anesthetized and bled immediately prior to sacrifice, and antibody assays were performed on those sera. Except when indicated, data are representative of at least duplicate experiments.
RESULTS
Colonization and systemic spread. Adult CD-1 females were given penicillin-tetracycline water beginning 3 days prior to intubation with viable C. albicans, and adult CBA/J males were given water containing trimethoprim-sulfamethoxazole beginning 2 days prior to intubation. Controls not treated with antibiotics were included in each experiment. Three animals were sacrificed at intervals thereafter, and stomachs, along with selected internal organs, were cultured quantitatively for C. albicans. In two other experiments, one involving CBA/J females not treated with antibiotics and another involving CBA/J males of which half had been treated with antibiotics, evaluations of colonization were based on fecal cultures only. Culture data for two representative experiments involving stomachs and internal organs are summarized in Table 1 . It is clear from the stomach data that the most substantial GI colonization occurred in animals treated with antibiotics. The data for CD-1 mice at 14 days, and CBA/J mice at 16 days in particular, illustrate that observation. Some CD-1 animals, however, remained colonized in the absence of antibiotics through the 28-day observation period. For some unknown reason, perhaps related to the different antibiotics being used, the CBA/J animals started out with fewer organisms in their stomachs shortly after inoculation, although culture of the inoculum indicated that a similar number of organisms was delivered to both CD-1 and CBA/J animals. Although systemic spread occurred in both strains of mice, it was erratic and small numbers of organisms were involved. In second experiments with both mouse strains, similar results were obtained with CD-1 mice, but even lower numbers were cultured from the stomachs of CBA/J mice on days 1 and 8. In addition, in the second experiment with CBA/J mice, cultures were taken 29 days after i.g. inoculation. Some of these animals had been inoculated with 106 C. albicans cutaneously as well. Of the 18 animals from whom samples were cultured at day 29, small numbers of organisms were detected outside the GI tract in only 2. Moreover, of the nine mice treated with antibiotics, eight had stomachs which were culture positive, including three mice which had been inoculated cutaneously but not i.g. Their respective controls, i.e., animals inoculated cutaneously but not receiving antibiotics, were all culture negative. Finally, for animals receiving antibiotics but not having been inoculated with C. albicans either i.g. or cutaneously, cultures were done 3 and 11 days following the initiation of antibiotics and all were negative.
In the experiments involving culture of fecal pellets, samples from CBA/J females never administered antibiotics were cultured at intervals after i.g. inoculation. Log1o CFU were challenged cutaneously only 1 week following i.g. inoculation. It was, however, demonstrable if the cutaneous booster inoculation was administered 2 weeks following i.g. inoculation. It was also clear that antibiotic treatment was not necessary for the animals to be primed by the colonization. In the experiment shown, animals inoculated i.g. and cutaneously in the absence of antibiotics had significantly greater responses to the membrane antigen (P < 0.05) than their counterparts inoculated cutaneously only, but that relationship was not a consistent finding. In fact, for the CBA/J mice (Fig. 1) , the response to the membrane antigen was the greatest in antibiotic-treated mice receiving both i.g. and cutaneous inoculations. In the absence of antibiotics, mice inoculated both i.g. and cutaneously and mice inoculated cutaneously only, in either the presence or absence of antibiotics, all had positive responses of the same order of magnitude, although the interval between i.g. and cutaneous inoculation in the animals in which comparisons were made in the presence or absence of antibiotics was 3 weeks rather than 2 weeks.
A somewhat different observation was made when other CBA/J males from the experiment just described were footpad tested with the cell wall antigen, GP, instead of the membrane extract, BEX (Fig.1) . In this instance, colonization alone, in the absence of a booster provided by cutaneous challenge, induced a low but significant level of DTH demonstrable with the GP. Furthermore, animals were primed by colonization in the presence or absence of antibiotics, so that when they were challenged cutaneously with viable organisms and then tested 7 days later for DTH, both groups responded with equally vigorous DTH responses. Finally, it was clear that antibiotic administration resulted in a slight enhancemnent of responsiveness to GP, regardless of the specific experimental group being observed, when that group was compared with the corresponding group not administered antibiotics. These differences could not be supported statistically but were reproducible from experiment to experiment. Female CBA/J mice, treated in the same manner as the males just described but in an experiment which involved no antibiotic administration, responded in the same manner as males, i.e., in the absence of cutaneous challenge, colonized animals had detectable DTH which was of the same order of magnitude as that for uncolonized animals which had been inoculated cutaneously only, while colonized animals which had also been inoculated cutaneously had DTH responses which were twice those of the animals that were colonized only or that had been inoculated cutaneously only.
Development of a protective response. Animals that had been colonized with C. albicans in the presence or absence of antibiotics, half of which had been inoculated cutaneously 3 weeks after the i.g. inoculation with viable C. albicans, were challenged, along with the respective control groups, with viable C. albicans i.v. to assess the development of a protective response. Protection was assessed by culture of both kidneys 26 to 28 days following the i.v. challenge. The data from three experiments, one involving CD-1 females challenged i.v. with 8 x 103 organisms, one involving CBA/J males challenged with 1.5 x 104 organisms, and one involving CBAIJ females challenged with 2.0 x 104 organisms, are summarized in Table 3 . Animals inoculated i.g. with viable C. albicans, in the presence or absence of antibiotic administration and with or without an additional cutaneous challenge with viable yeasts, had acquired a protective response demonstrable by the i.v. challenge. Animals inoculated cutaneously only did not develop protective responses which could be supported by statistical analysis, although in two of the three experiments, such animals had fewer CFU in their kidneys than unmanipulated control animals did. This observation was characteristic of the response of all animals not being administered antibiotics but receiving a single cutaneous inoculation with C. albicans followed by an i.v. challenge 1 week later, i.e., they developed either borderline or no protective responses. On the other hand, uncolonized animals given antibiotics and then inoculated once cutaneously with C. albicans acquired statistically significant (P < 0.05) protective responses. Since the GI tracts of cutaneously inoculated animals treated with antibiotics became colonized with C. albicans in the absence of specific i.g. inoculation, it is assumed that they develop their protective immunity in response to the combined stimulation afforded by the GI colonization and the cutaneous challenge. During the course of these studies, it became obvious to us that unimmunized male and female mice of the same strain were not equally susceptible to i.v. challenge with C. albicans but that they both appeared to develop strong protective responses. To confirm the initial impression, males and females were compared for the development of protective immunity in two separate experiments. The mice were immunized by being inoculated twice cutaneously with 106 viable C. albicans cells 2 weeks apart. At 2 weeks after the second inoculation, immunized and control animals were Table 4 . Clearly, males were innately more susceptible than females to i.v. challenge, but both were capable of developing equal levels of protective immunity.
Humoral response. At the time of sacrifice, 25 to 28 days following i.v. challenge, surviving mice were bled by cardiac puncture and their sera were tested by the enzyme-linked immunosorbent assay with an anti-mouse IgG antibody and with GP and SCS as antigens. These data are summarized in Table 5 . Three conditions led to enhanced GP-specific antibody formation, namely, i.g. inoculation of C. albicans followed by cutaneous inoculation, with or without antibiotic administration, and i.g. inoculation alone or cutaneous inoculation alone, both in animals given antibiotics. Furthermore, in the absence of antibiotic treatment, female mice produced somewhat higher levels of antibody to SCS than did males, and, in general, the response of females to GP was poorer. It was clear, however, that antibiotic administration had no adverse effect on antibody production to C. albicans antigens in mice. Since many of the titers were quite low, we looked for antibodies of other isotypes. No C. albicans-specific IgA could be detected, and only low titers of IgM were found (data not shown).
DISCUSSION
We have demonstrated in this paper that the continuous administration of penicillin-tetracycline to outbred albino mice or of trimethoprim-sulfamethoxazole to inbred CBA/J mice had no adverse effect on the development of acquired immune responses when such animals were inoculated i.g. or cutaneously with C. albicans and subsequently challenged i.v. with the same organism. In fact, the immune responses were usually greater in animals treated with antibiotics than in untreated animals. It is suspected that the reason for this phenomenon is that the antibiotics destroy the normal microbial balance in the gut and the fungus then increases in numbers there, resulting in a greater stimulation of the immune system. In support of this theory is the observation that more organisms were isolated from the stomachs of animals inoculated i.g. and treated with antibiotics than from the stomachs of animals inoculated i.g. but not treated with antibiotics. Furthermore, stomachs of animals inoculated cutaneously only but treated with antibiotics became culture positive. The stomachs of their counterpart controls not treated with antibiotics remained culture negative. The GI tract culture data, then, correlated well with the kidney culture data, which were gathered after i.v. challenge to assess protection. With the exception of animals inoculated both i.g. and cutaneously, a situation allowing for what appears to be maximum immune system stimulation, in all other situations when specific treatments were carried out in the presence or absence of antibiotics, the kidney cultures following i.v. challenge were always lower in the group tested with antibiotics.
Although immune responses were enhanced to the greatest extent in animals treated with antibiotics and colonized with C. albicans, antibiotic treatment was not a requirement for immune stimulation. For mals were inoculated cutaneously with viable C. albicans, they responded with heightened DTH and antibody titers to the wall glycoprotein, GP. It would appear, in fact, that there was substantial stimulation of the immune system in the absence of antibiotics as a direct result of considerably more colonization than has been suggested in previous studies (2) . The immunologic results obtained here are contradictory to most of the published studies on Candida spp. and their interaction with antibiotics, both in vivo and in vitro, although there is a considerable amount of controversy and confusion in the literature as well. A major problem when making comparisons is the fact that few people use the same methodology. Furthermore, in most in vivo studies that have been done, the antibiotic and the Candida spp. were both inoculated intraperitoneally (5, 25, 32, 33, 36) , and observations were made of innate responses, not of the development of acquired immunity. Seligmann (33) showed that the increased susceptibility of mice to challenge in the presence of the drug, in this instance chlortetracycline, could be demonstrated only for animals into which both drug and fungus were inoculated i.p. An i.v. inoculation of the drug and fungus resulted in data that were suggestive of a protective response. Since Winter and Foley (36) showed that the increased morbidity observed in mice inoculated i.p. was the result of invasion of the peritoneal surface of the kidneys, rather than hematogenous spread to kidneys, the tetracycline in the studies reported by Seligmann (33) probably caused severe irritation in the peritoneal cavity, with a resultant influx of inflammatory cells, which served to localize the Candida spp. to the cavity and decrease the potential for systemic spread. In another in vivo study, Gardner et al. (9) found a depression of phagocytic activity in pulmonary macrophages following oral sulfamethazine treatment. Finally, Thong and Ferrante (34) , using sheep erythrocytes as an immunogen, found a depression of the expression of DTH in animals treated with tetracycline.
In vitro studies of the interaction of antibiotics and the immune system have involved predominantly phagocytic and microbicidal function (6, 7, 13, 19, 35) . Lehrer (19) , for example, found that the sulfonamides interfered with the normal activities of human polymorphonuclear leukocytes, an effect which appeared to be involved with the myeloperoxidase-mediated pathway, and Welch et al. (35) showed reduced polymorphonuclear leukocyte activity in the presence of tetracycline and trimethoprim. Two other groups (1, 13) investigated the effect of antibiotics on in vitro cellular immune function. Banck and Forsgren (1) found no inhibitory effect of penicillin, sulfamethoxazole, or trimethoprim on lymphocyte proliferation to mitogens. On the other hand, Ganguly et al. (8) demonstrated suppression of the production of migration inhibitory factor in response to treatment with tetracycline. It appears, however, that even though certain abnormalities could be demonstrated in vitro, they did not influence the response to C. albicans in vivo under the conditions used by us, conditions which more nearly approximate the human situation, i.e., Candida spp. in the GI tract and long-term antibiotic administration.
Finally, in these studies, we confirmed the observation of Rifkind and Frey (29) of increased innate resistance on the part of the female mouse compared with the male of the same strain, to parenteral inoculation with C. albicans. We extended this observation, however, to study the development of acquired immunity and found that males and females were capable of generating protective responses of equal magnitude as assessed by quantitative kidney culture. Saslaw and Schaeffer (30) also found that females were more resistant than males to Histoplasma capsulatum, and female hamsters were found to be more resistant than males to Blastomyces dermatitidis (18) . However, in one of the fungal diseases for which there is a clear clinical difference between the apparent resistance of males and females, paracoccidioidomycosis (26) , the in vivo data for rats (15) do not correlate with the in vitro data with hormones (27) .
Taken as a whole, these studies demonstrate that penicillin-tetracycline and trimethoprim-sulfamethoxazole, used in concentrations equivalent to or greater than the normal adult human dosage, had no adverse effects on, nor were they required for the development of, Candida-specific systemic immune responses. Since systemic spread was rather limited following i.g. inoculation, and since the numbers were low 6% DOMER AND HECTOR 
